1. Home
  2. DNA vs DPG Comparison

DNA vs DPG Comparison

Compare DNA & DPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • DPG
  • Stock Information
  • Founded
  • DNA 2008
  • DPG 2011
  • Country
  • DNA United States
  • DPG United States
  • Employees
  • DNA N/A
  • DPG N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • DPG Trusts Except Educational Religious and Charitable
  • Sector
  • DNA Health Care
  • DPG Finance
  • Exchange
  • DNA Nasdaq
  • DPG Nasdaq
  • Market Cap
  • DNA 466.4M
  • DPG 450.4M
  • IPO Year
  • DNA N/A
  • DPG N/A
  • Fundamental
  • Price
  • DNA $8.57
  • DPG $12.03
  • Analyst Decision
  • DNA Sell
  • DPG
  • Analyst Count
  • DNA 3
  • DPG 0
  • Target Price
  • DNA $9.67
  • DPG N/A
  • AVG Volume (30 Days)
  • DNA 1.1M
  • DPG 150.1K
  • Earning Date
  • DNA 08-07-2025
  • DPG 01-01-0001
  • Dividend Yield
  • DNA N/A
  • DPG 9.09%
  • EPS Growth
  • DNA N/A
  • DPG N/A
  • EPS
  • DNA N/A
  • DPG N/A
  • Revenue
  • DNA $237,417,000.00
  • DPG N/A
  • Revenue This Year
  • DNA N/A
  • DPG N/A
  • Revenue Next Year
  • DNA $15.81
  • DPG N/A
  • P/E Ratio
  • DNA N/A
  • DPG N/A
  • Revenue Growth
  • DNA 13.76
  • DPG N/A
  • 52 Week Low
  • DNA $5.00
  • DPG $7.90
  • 52 Week High
  • DNA $18.40
  • DPG $13.58
  • Technical
  • Relative Strength Index (RSI)
  • DNA 55.25
  • DPG 41.05
  • Support Level
  • DNA $7.14
  • DPG $12.22
  • Resistance Level
  • DNA $10.02
  • DPG $12.37
  • Average True Range (ATR)
  • DNA 0.61
  • DPG 0.15
  • MACD
  • DNA 0.07
  • DPG -0.03
  • Stochastic Oscillator
  • DNA 53.53
  • DPG 15.00

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About DPG Duff & Phelps Utility and Infrastructure Fund Inc.

Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund. Its investment objective is to seek total return, resulting from a high level of current income, with an emphasis on providing tax-advantaged dividend income.

Share on Social Networks: